Ozempic is a brand-name version of the generic medication semaglutide, which is a type of medication called a glucagon-like peptide 1 receptor agonist. Instead of that tongue-twister of a name, we call these medications “GLP-1s” for short.
Ozempic is FDA-approved for the management of certain symptoms and risks of type 2 diabetes. Ozempic works by slowing the digestion process, which can help you to feel full for longer. Ozempic, like other GLP-1 receptor agonists, acts like a hormone your body naturally makes to regulate blood sugar and may help support weight loss.
Our partners will work directly with your insurance provider to help with the process of determining coverage for your GLP-1 medication, which is paid for separately from the Body Program. Ro does not accept insurance for the Body Program, which is cash pay only.
At this time, those with any form of government healthcare coverage (including programs such as Medicare, Medicare Supplement Plans, Medicaid or TRICARE), whether primary or secondary coverage are not eligible for the Body Program. These plans typically do not cover the type of medication the Body Program may prescribe. Unfortunately, this means that those on Medicare or eligible for Medicare cannot join the Body Program. Federal employees who receive their health insurance through the Federal Employee Health Benefits Program (FEHB) may participate in the Body Program.
Important Safety Information: Ozempic treats type 2 diabetes but may be prescribed off-label for weight loss, if appropriate. Ozempic may have serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of a type of thyroid cancer called MTC or MEN 2. Read more about serious warnings and safety info.
Reviews
There are no reviews yet.